The GOR gene product cannot cross-react with hepatitis C virus in humans

Area of Science:

• Immunology
• Virology
• Genetics

Background:

• The GOR47--1 epitope, a host-derived antigen, was identified for its cross-reactivity with hepatitis C virus (HCV).
• Its potential role in autoimmune phenomena associated with HCV infection and autoimmune hepatitis remains controversial.
• Enzyme immunosorbent assays (ELISA) using GOR47--1 show promise for HCV screening.

Purpose of the Study:

• To investigate the translation of the GOR47--1 epitope in humans.
• To explore the correlation between antibodies to GOR epitopes and autoimmune phenomena in HCV patients.
• To clarify the relationship between the GOR gene product and autoimmunity in humans.

Main Methods:

• Isolation of the human GOR gene.
• Analysis of GOR epitope translation in humans via genetic sequencing.
• Detection of antibodies against GOR epitopes (GOR47--1 and GOR1--125) in patient sera.
• Correlation analysis between antibody presence, autoimmune markers, and serum IgG levels.

Main Results:

• The GOR47--1 epitope is not translated in humans due to a single base substitution compared to chimpanzees.
• Antibodies against the translatable human GOR1--125 epitope were found in some patients.
• No correlation was observed between anti-GOR47--1 or anti-GOR1--125 antibodies and autoimmune phenomena.
• Serum IgG levels did not affect the titers of these antibodies.

Conclusions:

• The non-translation of the GOR47--1 epitope in humans suggests a minimal relationship between the GOR gene product and human autoimmunity.
• Further investigation into the cross-reactivity mechanisms between HCV and the GOR gene product is warranted.